VIRGINIA RETIREMENT SYSTEMS ET Al Invests $13.37 Million in Intuitive Surgical, Inc. $ISRG

VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 24,606 shares of the medical equipment provider’s stock, valued at approximately $13,371,000.

Several other institutional investors have also recently made changes to their positions in the company. Signature Estate & Investment Advisors LLC raised its position in shares of Intuitive Surgical by 85.0% in the 2nd quarter. Signature Estate & Investment Advisors LLC now owns 1,426 shares of the medical equipment provider’s stock worth $775,000 after acquiring an additional 655 shares in the last quarter. Quotient Wealth Partners LLC raised its position in shares of Intuitive Surgical by 9.0% in the 2nd quarter. Quotient Wealth Partners LLC now owns 1,791 shares of the medical equipment provider’s stock worth $973,000 after acquiring an additional 148 shares in the last quarter. Huntleigh Advisors Inc. raised its position in shares of Intuitive Surgical by 9.6% in the 2nd quarter. Huntleigh Advisors Inc. now owns 1,091 shares of the medical equipment provider’s stock worth $593,000 after acquiring an additional 96 shares in the last quarter. Chevy Chase Trust Holdings LLC raised its position in shares of Intuitive Surgical by 0.4% in the 2nd quarter. Chevy Chase Trust Holdings LLC now owns 371,248 shares of the medical equipment provider’s stock worth $201,740,000 after acquiring an additional 1,318 shares in the last quarter. Finally, Arista Wealth Management LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $781,000. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on ISRG shares. Evercore ISI decreased their target price on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research report on Tuesday, October 7th. Piper Sandler reaffirmed an “overweight” rating and set a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $615.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Finally, UBS Group set a $529.00 price objective on Intuitive Surgical in a research report on Monday, October 13th. Fourteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $580.29.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at approximately $325,669.91. The trade was a 31.19% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 45,224 shares of company stock valued at $21,716,492. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Up 2.6%

Intuitive Surgical stock opened at $446.13 on Monday. The firm has a market cap of $159.93 billion, a price-to-earnings ratio of 62.22, a PEG ratio of 4.69 and a beta of 1.61. The stock has a fifty day simple moving average of $454.97 and a two-hundred day simple moving average of $495.76. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.78 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.